Biochemical pharmacology of nonsteroidal anti-inflammatory drugs (Q41727005)

8 October 2017

1 reference

title

Biochemical pharmacology of nonsteroidal anti-inflammatory drugs (English)

1 reference

8 October 2017

Wu KK

1

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

8 October 2017

published in

Biochemical Pharmacology

1 reference

8 October 2017

volume

55

1 reference

8 October 2017

issue

5

1 reference

8 October 2017

page(s)

543-547

1 reference

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Aspirin selectively inhibits prostaglandin production in human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Prostaglandin endoperoxide synthase: structure and catalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Prostaglandin G/H Synthase-2 Is a Major Contributor of Brain Prostaglandins in the Newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Transcriptional regulation of endothelial constitutive PGHS-1 expression by phorbol ester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

L-745,337: a selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

7 January 2021

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Inhibition of NF-kappa B by sodium salicylate and aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Salicylate is a transcriptional inhibitor of the inducible nitric oxide synthase in cultured cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Inhibition of activator protein 1 activity and neoplastic transformation by aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Effect of sodium salicylate on the human heat shock response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

Salicylate Triggers Heat Shock Factor Differently than Heat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900342-0

10.1016/S0006-2952(97)00342-0

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference